Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05922657 · ClinicalTrials.gov registry record
A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device
A clinical trial of Menorrhagia and Heavy Menstrual Bleeding, sponsored by Channel Medsystems.
- Recruiting
- Registry status
- 300
- Enrollment target
- 2
- Study locations
NCT05922657 is a study of Menorrhagia and Heavy Menstrual Bleeding that is actively recruiting participants, run by Channel Medsystems. The registered enrollment target is 300 participants, above the 199-participant average among 10 other Menorrhagia trials with a reported enrollment target (51% higher). The trial reports 2 study locations across 2 states.
The verdict
NCT05922657, a study of Menorrhagia and Heavy Menstrual Bleeding, is actively recruiting participants, sponsored by Channel Medsystems.
- RECRUITING
- Registry status
- 300 participants
- Enrollment target
- 2
- Study locations
Study Summary
Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bridge the gap between clinical results and outcomes achieved and reported during the pivotal study of Cerene and those obtained during its real-world use.
Conditions Studied
Interventions
- DEVICE Cerene
Study Locations (2)
New Jersey
- Axia Women's Health / Rubino OB/GYN Group - West Orange
Ohio
- Seven Hills Women's Health Centers - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2023-06-09 |
| Est. Completion | 2027-12-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05922657
The ClinicalTrials.gov registry entry for NCT05922657 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 300 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 199-participant average among 10 other Menorrhagia trials with a reported enrollment target (51% higher). The listed sponsor is Channel Medsystems, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Menorrhagia appearing as the primary indexed condition, and to 1 intervention - of which Cerene is the first listed.
NCT05922657 reports 2 study locations spanning 2 distinct geographic areas - top geographies include New Jersey, Ohio.
Frequently Asked Questions
What is clinical trial NCT05922657 about?
NCT05922657 is a clinical study titled "A Registry to Gather Real World Use Data on the Cerene® Cryotherapy Device". Channel Medsystems, Inc., the manufacturer of the Cerene® Cryotherapy Device (Cerene), is initiating a prospective, observational registry, the Progress registry, to gather data during real world utilization of the Cerene® Cryotherapy Device (Cerene). The primary objective of this registry is to bri...
What is the current status of trial NCT05922657?
This trial is currently recruiting. The enrollment target is 300 participants. The study started on 2023-06-09. Estimated completion is 2027-12-31.
What conditions does trial NCT05922657 study?
This clinical trial studies the following conditions: Menorrhagia, Heavy Menstrual Bleeding, Abnormal Uterine Bleeding.
What interventions are being tested in trial NCT05922657?
The interventions under investigation include: Cerene (DEVICE).
Who is sponsoring clinical trial NCT05922657?
This trial is sponsored by Channel Medsystems, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05922657 being conducted?
This trial has 2 study locations across New Jersey, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Menorrhagia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Surgical Success After Laparoscopic vs Abdominal Hysterectomy
COMPLETED · NA
-
Ultrasound Appearance of the Endometrium Post Radio-Frequency Ablation
COMPLETED
-
Minerva Pivotal Study to Evaluate Safety and Efficacy of the Aurora Endometrial Ablation System Compared to Hysteroscopic Rollerball Ablation
COMPLETED · NA
-
Efficacy and Safety Study of XP12B in Women With Menorrhagia
COMPLETED · Phase 3
-
A Study of Tranexamic Acid (XP12B) in Women With Heavy Menstrual Bleeding
COMPLETED · Phase 3
-
Hysteroscopic Assessment of Fallopian Tubal Patency
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.